A new study has revealed that chemical analysis of blood samples combined with an Artificial Intelligence ( AI ) program can accelerate the diagnosis of brain tumors. The research was revealed at the 2019 National Cancer Research Institute (NCRI) Cancer conference at the Scottish Event Campus, Glasgow, Scotland.
Reporting from the page Medical News, Thursday (11/07/2019) brain tumors tend to have symptoms that are not specific. The initial symptoms are usually very common such as other illnesses such as headaches and memory problems. Otan scanning is the only way that can diagnose a brain tumor at this time.
Senior Clinical Lecturer and Surgery Consultant Sarah University of Edinburgh, UK, Dr. Paul Brennan revealed that brain tumors have reduced a person’s life expectancy by an average of 20 years. This expectation is the highest of all cancers.
Dr. Brennan has worked with Dr. Matthew Baker, a chemical analyst at the University of Strathclyde, UK, and chief scientific officer at ClinSpec Diagnostics Ltd. developing tests to help doctors have a quick and efficient way to find patients who are most likely to have tumors.
This test relies on an existing technique, called infrared spectroscopy, to check the chemical composition of a person’s blood, combined with an AI program that can find chemical clues that indicate the possibility of a brain tumor.